THE NICKLES GROUP, LLC for UCB, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to drug pricing. Monitored S. 3700 / H.R. 6833, Affordable Insulin Now Act. H.R. 7389, the MVP Act, issues related to the prescription drug value-based contracts.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Taxation/Internal Revenue Code TAX
H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to orphan drug tax credit, corporate and international taxes. H.R. 1304, the American Innovation and R&D Competitiveness Act; S. 749, the American Innovation and Jobs Act; and issues related to the R&D tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Health Issues HCR
S. 464 / H.R. 2163, the Safe Step Act and issues related to step therapy. S. 4348, FDASLA Act of 2022 and H.R. 7667, Food and Drug Amendments of 2022 and issues involving international inspections. Monitored issues related to mental health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.